Half-Year Statement on Liquidity Contract – Euronext Growth Paris
London, United Kingdom – 29 July 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), an international HealthTech and wellness company, today announces the half-year statement of its liquidity contract with TSAF – Tradition Securities And Futures, under the framework authorized by Euronext Growth Paris.
As of 30 June 2025, the following assets appeared in the liquidity account:
Number of shares: 267,741 ·
Cash balance: €7,347.23 (*) ·
For reference, at the time of the previous half-year statement on 31 December 2024, the following assets were recorded:
Number of shares: 47,992
Cash balance: €11,789.63
During the first half of 2025, the following transactions were carried out under the liquidity contract:
|
Transaction Type |
Number of Shares |
Number of Executions |
Amount (€) |
|
Purchases |
2,807,565 |
61 |
€51,490.08 |
|
Sales |
2,587,816 |
57 |
€46,951.00 |
(*) The positive difference in cash earnings as of 30 June 2025 includes interest applied to the liquidity account.
This statement is published pursuant to the provisions of Article 221-3 of the General Regulations of the French Financial Markets Authority (AMF).
The full report is available on the company’s website.
About Rapid Nutrition
Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).